0Critical Findings in the PV Audit
- Client
- Pharmaceutical company
- Service
- Audit & inspection
The challenge
A pharmaceutical company facing a regulatory PV audit was worried about weaknesses in its safety system and needed expert help to prepare against EU GVP, FDA 21 CFR Part 11 and ICH E2E.
Our solution
- Pre-audit gap assessment
- Remediation of PSMF, RMPs, ICSR and aggregate report records, audit trails and validation documents
- Training and mock audits
- On-site support during the audit
The results
- Audit passed with no critical findings
- Product authorisations maintained
- PV system aligned with global standards and updated SOPs
- Stronger relationship with the regulator
